In the US, Nicardipine (nicardipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Angina Pectoris Prophylaxis, Heart Failure and High Blood Pressure.
US matches:
- Nicardipine
- Nicardipine Capsules
- Nicardipine Sustained-Release Capsules
- Nicardipine Intravenous
- Nicardipine Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C08CA04
CAS registry number (Chemical Abstracts Service)
0055985-32-5
Chemical Formula
C26-H29-N3-O6
Molecular Weight
479
Therapeutic Category
Vasodilator, cerebral
Chemical Name
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester
Foreign Names
- Nicardipinum (Latin)
- Nicardipin (German)
- Nicardipine (French)
- Nicardipino (Spanish)
Generic Names
- Nicardipina (OS: DCIT)
- Nicardipine (OS: DCF, BAN)
- Nicardipine Hydrochloride (OS: BANM, JAN, USAN)
- RS 69216 (IS: Syntex)
- YC 93 (IS: Yamanouchi)
- Nicardipine Hydrochloride (PH: JP XIV)
Brand Names
- Loxen
Novartis, Tunisia - Apodipine
Kyowa Yakuhin, Japan - Aprovan
Fuji Yakuhin, Japan - Bionicard
Rottapharm, Italy - Cadibrain
CCPC, Taiwan - Cardene I.V.
ESP Pharma, United States - Cardene
Astellas, United Kingdom; Astellas, Netherlands; EKR, United States - Cardepine
Imperial, Philippines - Cardibloc
Imperial, Singapore - Cardip
Francia, Italy - Cartran
Choseido Pharmaceutical, Japan - Cepadipin
Daito, Japan - Coponent
Nisshin Seiyaku - Yamagata, Japan - Dagan
Tedec Meiji, Spain - Dromer
Yoshindo, Japan - Flusemide
Q-Pharma, Spain - Isedipeal
Isei, Japan - Kenicalnon
LA KemikkusuChemix, Japan - Lecibral
Desma, Spain - Lincil
Almirall, Egypt; Almirall, Spain; Almirall, Ghana; Almirall, Kenya; Almirall, Sudan; Almirall, Tanzania; Almirall, Zambia - Lisanirc
Lisapharma, Italy - Loxen
Novartis, Burkina Faso; Novartis, Benin; Novartis, Congo; Novartis, Cote D'ivoire; Novartis, Cameroon; Novartis, Algeria; Novartis, France; Novartis, Gabon; Novartis, Guinea; Novartis, Madagascar; Novartis, Mali; Novartis, Mauritania; Novartis, Mauritius; Novartis, Niger; Novartis, Senegal; Novartis, Togo; Novartis, Zaire - Lucenfal
Farma Lepori, Spain - Mitapilla
Kyorin Rimedio, Japan - Nerdipina
Ferrer, Spain; OM, Portugal - Nicadirus L
Shiono Kemikaru, Japan - Nicardal
Italfarmaco, Italy - Nicardipina Dorom
Dorom, Italy - Nicardipina Mylan
Mylan, Italy - Nicardipine Aguettant
Aguettant, France - Nicardipine Hydrochloride
Amneal, United States; Bedford, United States; Generamedix, United States; Mylan, United States; Navinta, United States; Par, United States; PharmaForce, United States; Sun, United States; Watson, United States; Wockhardt, United States - Nicardipino Ratiopharm
Ratiopharm, Spain - Nicardirate
Nipro PharmaNipurofama, Japan - Nicarpin
SF, Italy - Nicarpine
Pei Li, Taiwan; Sawai Seiyaku, Japan - Nicarun
Ohara Yakuhin, Japan - Nicaven
Farma1, Italy - Nicodel
Bayer Yakuhin, Japan - Nicodel LA
Bayer Yakuhin, Japan - Nisutadil
Towa Yakuhin, Japan - Palpedinon
Taisho Yakuhin, Japan - Palpedinon LA
Taisho Yakuhin, Japan - Perdipin LA
Astellas, Japan - Perdipina
Astellas, Italy - Perdipine
Astellas, China; Astellas, Indonesia; Astellas, Japan; Astellas, Taiwan - Plealpin
Tatsumi Kagaku, Japan - Radistmin
Taiyo Pharmaceutical, Japan - Radistmin L
Taiyo Pharmaceutical, Japan - Rydene
Astellas, Belgium; Astellas Pharma S.A., Luxembourg - Salipex
Nichi-Iko PharmaceuticalJMA, Japan; LA Nichi-Iko PharmaceuticalJMA, Japan - Tsurusepin
Tsuruhara Seiyaku, Japan - Vasodin
Teofarma, Italy - Vasonase
Astellas, Spain
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment